Table II.
Asymptomatic, %(n) | P-value Asymptomatic vs.Symptomatic | Symptomatic, %(n) | P-value Symptomatic vs. Ruptured | Ruptured, %(n) | ||||
---|---|---|---|---|---|---|---|---|
N | 3665 | 312 | 289 | |||||
Emergent case | 2.1 | (76) | <.001 | 26 | (82) | <.001 | 88 | (253) |
Distal Extenta | .12 | .32 | ||||||
Aortic | 47 | (1499) | 45 | (111) | 38 | (85) | ||
Common Iliac | 40 | (1280) | 39 | (96) | 42 | (94) | ||
External Iliac | 5.7 | (183) | 5.2 | (13) | 8.6 | (19) | ||
Internal Iliac | 7.4 | (237) | 12 | (29) | 11 | (24) | ||
Operation after day of admission | 12 | (446) | <.001 | 44 | (138) | <.001 | 13 | (36) |
Percutaneous Accessb | 27 | (972) | .01 | 20 | (61) | .34 | 23 | (66) |
Juxtarenal Aneurysm | 4.7 | (171) | .91 | 4.8 | (15) | .27 | 6.9 | (20) |
Main Body Device | .44 | .004 | ||||||
Cook Zenith | 21 | (752) | 18 | (56) | 24 | (70) | ||
Endologix Powerlink | 7.4 | (270) | 9.3 | (29) | 3.5 | (10) | ||
Gore Excluder | 33 | (1206) | 36 | (113) | 38 | (108) | ||
Medtronic Endurant | 30 | (1088) | 28 | (88) | 22 | (64) | ||
Otherc | 8.9 | (325) | 8.0 | (25) | 12 | (35) | ||
Concommitant Procedures | ||||||||
Access Vessel Conduit/Repair | 7.4 | (271) | .04 | 11 | (33) | .01 | 18 | (52) |
Hypogastric Embolization | 6.6 | (241) | .91 | 6.4 | (20) | .23 | 9.0 | (26) |
Lower Ext. Revascularizationa | 3.5 | (129) | .08 | 5.4 | (312) | .12 | 8.7 | (25) |
Aortic Bare Metal Stent | 2.1 | (78) | .89 | 2.2 | (7) | .55 | 1.4 | (4) |
Iliac Bare Metal Stent | 3.4 | (124) | .87 | 3.2 | (10) | .86 | 3.5 | (10) |
Patients missing data (12.7%) for concomitant lower extremity revascularization, defined as any bypass or stent to an infrainguinal artery, coded as “No” because unlikely to have had the procedure and not be captured. The 12.7% missing data from distal extent were kept as missing.
Attempted percutaneous access counted as percutaneous
Other main body device includes: Cook Zenith Fenestrated and Renu, Lombard Aorfix, Medtronic Aneurx, Medtronic Talent, Not documented, Other, Trivascular Ovation